TrialHuman vaccines & immunotherapeutics2026

Safety and durability of influenza and SARS-CoV-2 antibody responses through 6 months after a single dose of mRNA-1083, a multicomponent influenza and COVID-19 vaccine, in adults ≥50 years.

Lusine Kostanyan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.